Dermata Therapeutics, Inc. DRMA Q1 2026 earnings

FAQ

When did Dermata Therapeutics, Inc. report Q1 2026 earnings?

Dermata Therapeutics, Inc. (DRMA) reported Q1 2026 earnings on May 13, 2026 before market open.

What were Dermata Therapeutics, Inc.'s Q1 2026 revenue and EPS?

Dermata Therapeutics, Inc. reported eps of $-0.48 for Q1 2026.

Did Dermata Therapeutics, Inc. beat estimates in Q1 2026?

EPS beat the consensus estimate of $-0.53 by $0.05.

How did Dermata Therapeutics, Inc.'s Q1 2026 results compare year-over-year?

Compared to the same quarter a year prior, eps grew 89.3% from $-4.50.

Where can I find Dermata Therapeutics, Inc.'s Q1 2026 SEC filings?

You can read the 8-K earnings release (0001493152-26-022710) and the 10-Q periodic report (0001493152-26-022719) directly on SEC EDGAR. The filing index links above go to sec.gov.